Patients with oligometastatic disease can be divided into 3 cohorts (7,8): 1) patients who present with oligometastases; 2) patients with residual oligometastases after systemic therapy; and 3) those with relapsed oligometastases after curative locoregional therapy. These different groups have possibly distinct prognoses, and may need differential approaches.